Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator

about

A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.

P2860

Q42707414-D93D67FE-2CB1-4572-B154-C18B7AB8E431

P2860

Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator

Item

http://www.wikidata.org/entity/Q28544827

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@ast

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@en

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@nl

type

Item

label

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@ast

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@en

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@nl

prefLabel

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@ast

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@en

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@nl

P1476

Potentiation of insulin-mediat ...... ule insulin receptor modulator

@en

P2093

Ge Dai

http://www.w3.org/2001/XMLSchema#string

Jun Yao

http://www.w3.org/2001/XMLSchema#string

Liangsu Wang

http://www.w3.org/2001/XMLSchema#string

Margaret Wu

http://www.w3.org/2001/XMLSchema#string

Scott Hoyt

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses

Oral insulin delivery: how far are we?

Identification of novel orally available small molecule insulin mimetics.

Identification of a molecular activator for insulin receptor with potent anti-diabetic effects.

A novel small molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose mimics the antiplatelet actions of insulin

Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks

Structural basis of allosteric ligand-receptor interactions in the insulin/relaxin peptide family: implications for other receptor tyrosine kinases and G-protein-coupled receptors.

Small molecule activators of the insulin receptor: potential new therapeutic agents for the treatment of diabetes mellitus.

Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity

P304

e0122012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2346807

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0122012

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James Mu

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274026332

http://www.w3.org/2001/XMLSchema#string

P698

25799496

http://www.w3.org/2001/XMLSchema#string

P921

hypoglycemia

Insulin

P932

4370409

http://www.w3.org/2001/XMLSchema#string

Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator

about

P2860

P2860

Potentiation of insulin-mediated glucose lowering without elevated hypoglycemia risk by a small molecule insulin receptor modulator

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932